GAO criticizes FDA's inspections of foreign drug makers
Pharma Compliance Alert, November 7, 2007
The FDA can only identify inspection records for one-third of foreign pharmaceutical manufacturers, according to a Government Accountability Office (GAO) report.
According to the GAO report, the FDA oversees 3,249 foreign manufacturers, although they may not all export pharmaceuticals to the U.S. The FDA conducts an average of 241 inspections each year, which equates to roughly 7% of manufacturers.
The report also said the FDA does not have an exact number of the foreign manufacturers it oversees because different agency databases provide different estimates. Even when the FDA conducts inspections of foreign manufacturers, it must rely on the manufacturer for translators.
Click here to read more in the Wall Street Journal. Click here to read the GAO's report.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched
